Trials / Completed
CompletedNCT03484104
Cerebral Perfusion in Hypothermic Circulatory Arrest
Cerebral Perfusion During Cardiac Surgery With Hypothermic Circulatory Arrest
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Selective antegrade cerebral perfusion (sACP) during aortic arch surgery in hypothermic circulatory arrest (HCA) is an established method for intraoperative neuroprotection. Although sACP is established as a beneficial method to reduce secondary neurological side effects due to brain-malperfusion, there are several parameters like sACP flow rate, perfusion pressure or temperature of the perfusate, where the optimal values remain unclear. The flow rate of the sACP-perfusate is increased according to center-specific standard-procedures. The optimal sACP flow rate, monitored by near infrared spectroscopy (NIRS), is to be investigated in this single center clinical prospective observational study. 40 Patients are enrolled over an estimated period of 14 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Measurement of tissue oxygenation index (TOI) | TOI and Vmca measurement during cardiac surgery with hypothermic circulatory arrest |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2021-09-28
- Completion
- 2021-09-28
- First posted
- 2018-03-30
- Last updated
- 2021-09-29
Locations
2 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03484104. Inclusion in this directory is not an endorsement.